Document is current
Any future updates will be listed below
-
Authors
Tombling, Benjamin J.
Cai, Fei
Wendorff, Timothy J.
Ogasawara, Annie
Gill, Herman S.
Tinianow, Jeff N.
Chang, Andrew
Balana, Aaron T.
Peng, Lingling
Miller, Stephen E. https://orcid.org/0000-0002-6988-2465
Walters, Benjamin T. https://orcid.org/0000-0001-5400-0696
Lictao, Aaron
Yu, Qinying
DeWitt, David C.
Wei, Yuehua
Wu, Sunny Z. https://orcid.org/0000-0002-6153-0449
Sudhamsu, Jawahar https://orcid.org/0000-0003-0737-2299
Krishnamurty, Akshay T.
Williams, Simon P.
Marik, Jan
Zhang, Yingnan
Maun, Henry R. https://orcid.org/0000-0002-4909-6061
Kirchhofer, Daniel
-
Funding
Funding for this research was provided by:
This work was funded by Genentech, Inc. member of the Roche Group.
- License Information
-
More Information
Article History
Received: 16 May 2025
Accepted: 13 May 2026
First Online: 5 June 2026
Competing interests
: All authors, except for A.C., were employees of Genentech, Inc. at the time the work was conducted. The authors B.J.T., F.C., Y.Z., H.R.M., D.K., A.T.B., and T.J.W. are named as inventors on the patent application WO2025193946 related to the peptides described in this study. This patent application covers the molecular design, sequences, diagnostic and therapeutic use of the LRRC15-binding peptides reported in this article. The remaining authors declare no competing interests.
